Microwave ablation versus parathyroidectomy for severe secondary hyperparathyroidism in patients on hemodialysis: a retrospective multicenter study

References

• Dang Z, Tang C, Li G, et al. Mineral and bone disorder in hemodialysis patients in the Tibetan Plateau: a multicenter cross-sectional study. Ren Fail. 2019;41:636–643.
   PubMed Web of Science ®Google Scholar
• Tentori F, Wang M, Bieber BA, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. CJASN. 2015;10:98–109.
   PubMed Web of Science ®Google Scholar
• Seo KW, Park JS. Myocardial calcification due to uncontrolled hyperparathyroidism. J Korean Med Sci. 2018;33:e162.
   PubMed Web of Science ®Google Scholar
• Wan J, Li W, Zhong Y. Parathyroidectomy decreases serum intact parathyroid hormone and calcium levels and prolongs overall survival in elderly hemodialysis patients with severe secondary hyperparathyroidism. J Clin Lab Anal. 2019;33:e22696.
   PubMed Web of Science ®Google Scholar
• Ivarsson KM, Akaberi S, Isaksson E, et al. Cardiovascular and cerebrovascular events after parathyroidectomy in patients on renal replacement therapy. World J Surg. 2019;43:1981–1988.
   PubMed Web of Science ®Google Scholar
• Plas W, Dulfer RR, Koh EY, et al., on behalf of the Dutch Hyperparathyroidism Study Group (DHSG). Safety and efficacy of subtotal or total parathyroidectomy for patients with secondary or tertiary hyperparathyroidism in four academic centers in the Netherlands. Langenbecks Arch Surg. 2018;403:999–1005.
   PubMed Web of Science ®Google Scholar
• Filho WA, van der Plas WY, Brescia M, et al. Quality of life after surgery in secondary hyperparathyroidism, comparing subtotal parathyroidectomy with total parathyroidectomy with immediate parathyroid autograft: prospective randomized trial. Surgery. 2018;164:978–985.
   PubMed Web of Science ®Google Scholar
• Zhang J, Qiu M, Sheng J, et al. Ultrasound-guided percutaneous thermal ablation for benign parathyroid nodules. Acad J Second Mil Med Univ. 2013;33:362–370.
   Google Scholar
• Wang G, Liu S, Liu X, et al. Microwave ablation: an effective treatment for mild-to-moderate secondary hyperparathyroidism in patients undergoing haemodialysis. Int J Hyperthermia. 2017;33:1–52.
   PubMed Web of Science ®Google Scholar
• Wei Y, Peng LL, Zhao ZL, Li Y, et al. Complications encountered in the treatment of primary and secondary hyperparathyroidism with microwave ablation - a retrospective study. Int J Hyperthermia. 2019;36:1264–1271.
   PubMed Web of Science ®Google Scholar
• Zhuo L, Peng LL, Zhang YM, et al. US-guided microwave ablation of hyperplastic parathyroid glands: safety and efficacy in patients with end-stage renal disease-a pilot study. Radiology. 2017;282:576–584.
   PubMed Web of Science ®Google Scholar
• Zhao J, Qian L, Zu Y, et al. Efficacy of ablation therapy for secondary hyperparathyroidism by ultrasound guided percutaneous thermoablation. Ultrasound Med Biol. 2016;42:1058–1065.
   PubMed Web of Science ®Google Scholar
• Li X, Wei Y, Shao H, et al. Efficacy and safety of microwave ablation for ectopic secondary hyperparathyroidism: a feasibility study. Int J Hyperthermia. 2019;36:647–653.
   PubMed Web of Science ®Google Scholar
• Diao Z, Liu X, Qian L, et al. Efficacy and its predictor in microwave ablation for severe secondary hyperparathyroidism in patients undergoing haemodialysis. Int J Hyperthermia. 2016;32:614–622.
   PubMed Web of Science ®Google Scholar
• Gong L, Tang W, Lu J, et al. Thermal ablation versus parathyroidectomy for secondary hyperparathyroidism: a meta-analysis. Int J Surg. 2019;70:13–18.
   PubMed Web of Science ®Google Scholar
• Jiang B, Wang X, Yao Z, et al. Microwave ablation vs. parathyroidectomy for secondary hyperparathyroidism in maintenance hemodialysis patients. Hemodial Int. 2019;23:247–253.
   PubMed Web of Science ®Google Scholar
• Diao Z, Wang L, Li D, et al. Efficacy of microwave ablation for severe secondary hyperparathyroidism in subjects undergoing hemodialysis. Ren Fail. 2017;39:140–145.
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42:S1–S201.
   PubMed Web of Science ®Google Scholar
• Lau WL, Obi Y, Kalantar-Zadeh K. Parathyroidectomy in the management of secondary hyperparathyroidism. Clin J Am Soc Nephrol. 2018;13:952–961.
   PubMed Web of Science ®Google Scholar
• KDIGO CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1–59.
   Web of Science ®Google Scholar
• Ho LC, Hung SY, Wang HH, et al., Tainan RENal Disease Study (TRENDS) group. Parathyroidectomy associates with reduced mortality in Taiwanese dialysis patients with hyperparathyroidism: evidence for the controversy of current guidelines. Sci Rep. 2016;6:19150.
   PubMed Web of Science ®Google Scholar
• Ivarsson KM, Akaberi S, Isaksson E, et al. The effect of parathyroidectomy on patient survival in secondary hyperparathyroidism. Nephrol Dial Transplant. 2015;30:2027–2033.
   PubMed Web of Science ®Google Scholar
• Komaba H, Taniguchi M, Wada A, et al. Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int. 2015;88:350–359.
   PubMed Web of Science ®Google Scholar
• Kestenbaum B, Andress DL, Schwartz SM, et al. Survival following parathyroidectomy among United States dialysis patients. Kidney Int. 2004;66:2010–2016.
   PubMed Web of Science ®Google Scholar
• Chen L, Wang K, Yu S, et al. Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis. Ren Fail. 2016;38:1050–1058.
   PubMed Web of Science ®Google Scholar
• Apetrii M, Goldsmith D, Nistor I, et al. Impact of surgical parathyroidectomy on chronic kidney disease-mineral and bone disorder (CKD-MBD) – a systematic review and meta-analysis. PLoS One. 2017;12:e0187025.
   PubMed Web of Science ®Google Scholar
• Fukagawa M, Yokoyama K, Koiwa F, et al., Japanese Society for Dialysis Therapy. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial. 2013;17:247–288.
   PubMed Web of Science ®Google Scholar
• Floege J, Kim J, Ireland E, et al., on behalf of the ARO Investigators. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant. 2011;26:1948–1955.
   PubMed Web of Science ®Google Scholar
• Fernández-Martín JL, Martínez-Camblor P, Dionisi MP, et al. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. Nephrol Dial Transplant. 2015;30:1542–1551.
   PubMed Web of Science ®Google Scholar
• Lee SA, Lee MJ, Ryu GW, et al. Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients. Osteoporos Int. 2016;27:2717–2726.
   PubMed Web of Science ®Google Scholar
• Jean G, Lataillade D, Genet L, et al. Association between very low PTH levels and poor survival rates in haemodialysis patients: results from the French ARNOS cohort. Nephron Clin Pract. 2011;118:c211–6.
   PubMed Web of Science ®Google Scholar